Therapeutic Targeting of MZF1‐AS1 /PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression

Author:

Fang Erhu1,Wang Xiaojing2,Yang Feng1,Hu Anpei1,Wang Jianqun1,Li Dan1,Song Huajie1,Hong Mei1,Guo Yanhua1,Liu Yang1,Li Hongjun3,Huang Kai2,Zheng Liduan23,Tong Qiangsong12ORCID

Affiliation:

1. Department of Pediatric SurgeryUnion HospitalTongji Medical CollegeHuazhong University of Science and Technology 1277 Jiefang Avenue Wuhan 430022 Hubei Province P. R. China

2. Clinical Center of Human Genomic ResearchUnion HospitalTongji Medical CollegeHuazhong University of Science and Technology 1277 Jiefang Avenue Wuhan 430022 Hubei Province P. R. China

3. Department of PathologyUnion HospitalTongji Medical CollegeHuazhong University of Science and Technology 1277 Jiefang Avenue Wuhan 430022 Hubei Province P. R. China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3